Cytokinetics Inc. buy Needham & Company LLC
Start price
09.04.24
/
50%
€68.00
Target price
09.04.25
€99.24
Performance (%)
-13.97%
Price
29.04.24
€58.50
Summary
This prediction is currently active. The prediction for Cytokinetics Inc. disappoints with a performance of -13.97%. This prediction currently runs until 09.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Cytokinetics Inc. | -6.400% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $108.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€71.00
28.02.24
28.02.24
€99.73
28.02.25
28.02.25
-17.61%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€73.50
27.12.23
27.12.23
€97.23
27.12.24
27.12.24
-20.41%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€31.40
20.10.23
20.10.23
€56.68
20.10.24
20.10.24
92.68%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
93.71%
29.04.24
29.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24